PRODUCT INFORMATION
Description
NGR Peptide TFA (Cys-Asn-Gly-Arg-Cys) is a peptide containing the Asn-Gly-Arg (NGR) motif, which is known to bind to the APN/CD13 receptor. This property makes it well-suited for direct conjugation to various imaging agents (e.g., 68Ga, 99mTc) or nanoparticles for the purpose of researching in vivo tumor detection models and studying CD13-mediated targeting.
Molecular Weight
722.72
Purity
> 95%
Formula
C₂₂H₃₇F₃N₁₀O₁₀S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Gly-Arg-Cys-Gly
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) Targeting Peptide (CAT#: OLY-1025-YS-62)
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.